Roche’s navify Digital Pathology software platform now offers Ibex’s Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of breast and prostate cancer. Roche and Ibex cloud-based digital...

Ibex: More Than 10,000 Patient Cases Diagnosed Using Ibex's AI Platform; CorePlus Expands its AI Deployment to Primary Diagnosis  BOSTON and CAROLINA, Puerto Rico, Oct. 10, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader...

Ibex: Developed in Collaboration with AstraZeneca and Daiichi Sankyo, Galen™ Breast HER2 Aids Pathologists with Reproducible HER2 Assessment  TEL AVIV, Israel, Sept. 7, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in...

Join Ibex at ECP 2023 in Dublin to learn how they transform cancer diagnosis by harnessing artificial intelligence to support routine practice at pathology labs worldwide. There will be three clinical presentations from studies conducted at...

Ibex: NHS Expands Access to Ibex’s Galen™ Breast and Galen™ Prostate Solutions to 25 Trusts Across the UK Following PathLAKE Plus Consortium Bid Wins Tel Aviv, Israel – March 7, 2023 – Ibex Medical Analytics (Ibex), the leader...

Ibex: Pathology Diagnostics Platform Meets Safety, Quality and Performance Criteria Under EU's New In Vitro Diagnostic Medical Devices Regulation. TEL AVIV, Israel, Feb. 9, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in...